14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 12 days ( -150.00 % )
Last Price $0.0005 0 %
High/ Low $0.0005 - $0.0005 60.00%
Chg 7 Days 150.00 % $0.0002 $0.0005
Chg 30 Days 66.67 % $0.0003 $0.0005
Chg 12 mos -95.58 % $0.0113 $0.0005
Trend - 3 mos -31.90 % Width: 341.84 %
Trend - 12 mos -65.82 % Width: 160.84 %
Pred. range - 3 mos N/A - $0.0003 -100.00 % - -32.41 %
Pred. range - 12 mos N/A - $0.0016 -100.00 % - 218.04 %
Short MA avg 3 mos Sell Apr 12, 2024 - 16 days
Long MA avg 3 mos Buy Apr 17, 2024 - 13 days
Short/Long MA avg 3 mos Buy Apr 23, 2024 - 9 days
Short MA avg 12 mos Buy Apr 17, 2024 - 13 days
Long MA avg 12 mos Buy Apr 30, 2024 - 4 days
Short/Long MA avg 12 mos Sell Feb 22, 2024 - 51 days
Pivot Short Sell May 02, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Buy No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Q BioMed Inc.

Q BioMed. Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-v... QBIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT